Coty Inc. — Form 10-Q Summary
Reporting period: Fiscal quarter and six months ended December 31, 2015. Coty manufactures and markets fragrances, color cosmetics, and skin and body care products in more than 130 countries. Its fiscal year ends June 30; holiday-season demand makes results and cash flows seasonal.
Financial performance
| Metric | Three months ended Dec. 31, 2015 | Six months ended Dec. 31, 2015 |
|---|---|---|
| Net revenue | $1,210.5 million; down 4% | $2,322.8 million; down 5% |
| Gross profit / margin | $742.8 million / 61.4% | $1,411.4 million / 60.8% |
| Operating income / margin | $152.4 million / 12.6% | $234.1 million / 10.1% |
| Adjusted operating income / margin | $214.6 million / 17.7%; up 7% | $388.0 million / 16.7%; up 5% |
| Net income attributable to Coty | $89.0 million; diluted EPS $0.25 | $214.7 million; diluted EPS $0.59 |
| Adjusted net income attributable to Coty | $135.8 million; adjusted diluted EPS $0.38 | $355.5 million; adjusted diluted EPS $0.98 |
| Cash from operations | Not reported separately for the quarter | $517.1 million |
Quarterly gross margin improved about 180 basis points and six-month gross margin improved about 140 basis points year over year. Management attributed the gains mainly to reduced promotions and supply-chain savings. Adjusted measures are non-GAAP and exclude specified costs and other items; they should be considered alongside GAAP results.
Revenue by segment
- Quarter: Fragrances $627.0 million, down 9%; Color Cosmetics $374.8 million, up 10%; Skin & Body Care $208.7 million, down 8%.
- Six months: Fragrances $1,175.1 million, down 12%; Color Cosmetics $765.7 million, up 12%; Skin & Body Care $382.0 million, down 10%.
Reported revenue declines reflected substantial adverse foreign-exchange translation. For the quarter, management cited a 7% FX headwind, lower volume partly offset by favorable price and mix, and a 13% revenue contribution from Bourjois to Color Cosmetics. Excluding FX, Bourjois, and the TJoy/China changes, total revenue declined 1% in both the quarter and six-month period. Fragrance weakness included soft mass-market demand and declines in mature brands; color cosmetics benefited from Bourjois and Sally Hansen, while Skin & Body Care faced FX and volume pressure.
Cash, debt, and liquidity
- Cash and equivalents were $482.7 million at December 31, 2015, versus $341.3 million at June 30, 2015.
- Six-month operating cash flow was $517.1 million, compared with $355.0 million. Investing used $543.7 million, including the $429.4 million advance for the Brazilian Beauty Business; financing provided $193.9 million. Ending cash increased $141.4 million.
- Total debt was $3,662.4 million, versus $2,634.7 million at June 30; long-term debt, net, was $3,570.9 million. The increase chiefly reflects refinancing and borrowing activity.
- In October 2015, Coty refinanced prior facilities with a secured credit agreement that includes a $1.5 billion revolver, $1.75 billion Term Loan A, and Term Loan B facilities. The company reported compliance with its leverage covenant at period end; the maximum was 5.50-to-1.00 through December 31, 2016, subject to stated acquisition provisions and later step-downs.
- Coty said available cash, operating cash generation, and credit access were sufficient for near- and long-term needs. It paid $89.0 million in cash dividends during the six months and repurchased $700.0 million of shares under its authorization.
Material changes, outlook, and notable items
- GAAP quarterly operating income fell 17%, while adjusted operating income rose 7%. Higher acquisition-related costs were a major difference: $45.5 million in quarterly expense and $61.3 million for six months. Six-month restructuring costs were $72.7 million, and a $5.5 million long-lived-asset impairment was recorded.
- Six-month Coty-attributable net income rose to $214.7 million from $136.0 million, principally because of a $193.9 million IRS settlement tax benefit and the prior-year $88.8 million debt-extinguishment loss. The tax benefit included $164.2 million from additional deferred tax assets and $29.7 million from reduced unrecognized tax benefits; $113.0 million was offset by a valuation allowance. The six-month effective tax rate was negative 30.6%.
- Quarterly results also included $24.1 million of other expense, mainly foreign-currency-contract losses related to the Brazilian transaction advance. Management identified one-time derivative gains that reduced reported net interest expense.
- The $700 million repurchase authorization was completed. Subsequent to quarter-end, Coty authorized an additional $500 million repurchase program, with no set completion date.
- Coty completed its approximately $886.7 million Brazilian Beauty Business acquisition on February 1, 2016, financed with cash and credit-facility drawings. The purchase-price allocation was not yet complete.
- The proposed P&G Specialty Beauty transaction was expected to close in the second half of calendar 2016, subject to regulatory and other conditions. As of December 31, the estimated transaction value was approximately $13.0 billion, including shares representing 52% of the combined company and assumed debt; final value would depend on closing-date factors.
- Management described challenging markets, particularly mass fragrance in Western Europe and the U.S., and expected gradual decline in non-power brands later in their lifecycles. It emphasized growth of ten power brands, innovation, market execution, emerging-market expansion, and channel diversification. The filing provides no quantified full-year earnings or revenue guidance.
- Risks include foreign-exchange volatility, weak consumer or regional markets, acquisition integration and financing, retailer and channel shifts, product acceptance, restructuring execution, and seasonal cash needs. Coty also disclosed a reasonably possible material penalty related to a U.S. antiboycott compliance matter; no reserve was recorded and the amount, if any, was unknown. A securities class action relating to the IPO remained pending, and the company intended to defend it.
Important facts for investors to verify
- Whether underlying volume and demand improve, particularly in mass fragrances and the U.S. nail market, and whether reported growth remains dependent on acquisitions or favorable price and mix.
- How recurring margins and cash generation compare with adjusted results after acquisition, restructuring, and integration costs.
- Debt and covenant headroom after the Brazilian acquisition and pending P&G transaction, including the effects of interest rates and foreign exchange.
- The final Brazilian acquisition allocation and integration performance, and the timing, terms, and dilution implications of the P&G transaction.
- Resolution and potential financial or reputational consequences of the antiboycott matter and pending securities litigation.